Global Multimodal Imaging Market Size, Trends & Growth Opportunity, By Product (Multimodal Imaging Equipment, Reagents, and Software), By Technology (PET/MR Systems, SPECT/CT Systems, PET/CT Systems, OCT/Fundus Imaging Systems, and Others), By Application (Ophthalmology, Oncology, Cardiology, Brain & Neurology, and Others), By Region and Forecast till 2027.
Global Multimodal Imaging Market
Global Multimodal Imaging Market was valued at USD 2.7 billion in 2022 and is slated to reach at USD 3.41 billion by 2027 at a CAGR of 4.1% from 2022-2027.
Multimodal imaging is defined as the therapeutically combining fundamental benefits of two or more imaging techniques to create stronger paradigm of imaging. These are used for early detection of diseases associated with Ophthalmology, Oncology, Cardiology, Brain & Neurology, and Others. Also, they have ability to detect of tumor lesions for accurate treatment delivery.
Market Drivers
Rise in technological advancements in diagnostic imaging modalities is key driving factor which is expected to boost the global multimodal imaging market growth. Also, increase in application of multimodal imaging in Ophthalmology, Oncology, Cardiology, Brain & Neurology, and Others will positively influence the market growth. Furthermore, increase in healthcare expenditure and rise in aging population will fuel the market growth during this forecast period. Moreover, rise in prevalence of chronic diseases like cancer and diabetes which expected to drive the market growth
Market Restraints
However, high cost of multimodal imaging is the major challenging factor which is expected to hinder the global multimodal imaging market growth. Also, lack of adequate healthcare infrastructure is also another challenging factor which is expected to hamper the market growth during this analysis period.
Impact of COVID-19
Medical supplies are increasingly in demand as a result of the afflicted population. Among the most common medical devices used in first-line clinical care are respiratory support devices such atomizers, life support machines, oxygen generators, and monitors. Additionally, COVID-19 has caused a significant increase in demand for medical goods such masks, gloves, and protective eyewear. To maintain a sufficient and ongoing supply of personal protective equipment in the market, manufacturers of these items have the opportunity to take advantage of the rising demand for medical supplies.
Recent developments
United Imaging Healthcare Co., Ltd. unveiled uEXPLORER, its full body PET/CT technology, on January 22nd, 2019.
GE Healthcare unveiled the 800 series SPECT/CT systems on June 24th, 2018 together with additional technologies like NM/CT 860, NM/CT 850, NM/CT 870 DR, and NM/CT 870 CZT.
Market Segmentation
Global Multimodal Imaging Market is segmented into product such as Multimodal Imaging Equipment, Reagents, and Software, by technology such as PET/MR Systems, SPECT/CT Systems, PET/CT Systems, OCT/Fundus Imaging Systems, and Others, by application such as Ophthalmology, Oncology, Cardiology, Brain & Neurology, and Others. Further, market is segmented into end user such as Hospitals, Diagnostic Imaging Centers, and Other.
Regional Analysis
Also, Global Multimodal Imaging Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Player
Various key players are discussed in this report such as GE Healthcare, Canon, Inc., Heidelberg Engineering, Infraredx, Inc., Koninklijke Philips N.V., Mediso Medical Imaging Systems Kft, Neusoft Medical Systems Co., Ltd, Siemens Healthineers, Spectrum Dynamics Medical, and Topcon Corporation
Market Taxonomy
By Product
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook